Sapient Capital »

Ascendis Pharma AS shares owned by Sapient Capital

Quarter-by-quarter ownership of Ascendis Pharma AS shares owned by Sapient Capital from 13F filings

Historical chart of Sapient Capital investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Sapient Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Sapient Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $25M 92k 266.72

More positions owned by Sapient Capital

Eli Lilly & Co. (LLY)
Ea Series Trust Sapient Quality (SQS)
Applovin Corp Com Cl A (APP)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
JPMorgan Chase & Co. (JPM)
Vistra Energy (VST)
Steel Dynamics (STLD)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ge Vernova (GEV)
Micron Technology (MU)

View all positions for Sapient Capital

Top funds holding Ascendis Pharma AS

A.R. Schmeidler & Co
Driehaus Capital Management
Q Global Advisors
Sapient Capital
Tudor Investment Corporation
Handelsbanken Fonder AB
Henry James International Management
Evolutionary Tree Capital Management
Ohio Pers
Legato Capital Management
PSP Research
Assenagon Asset Management
GAMMA Investing
Massmutual Trust
SBI Securities

View all funds holding Ascendis Pharma AS